- India’s largest drugmaker Sun Pharma to buy U.S. firm Organon in $11.75 billion deal CNBC
- Sun Pharma to Buy U.S. Healthcare Firm Organon in $11.75 Billion Deal WSJ
- Sun Pharma to acquire US-based Organon in $11.75 billion deal, among biggest overseas buys by Indian firms The Times of India
- Sun Pharma to Acquire US-Listed Organon in $12 Billion Deal Bloomberg
- Sun Pharma shares jump over 5% after Organon acquisition; Macquarie sees debt-free status in 3-4 years Moneycontrol.com
